MD Biosciences
Postfach 211
Gewerbestrasse 9
Zürich
8032
Tel: 41-1-986-2628
Fax: +41-1-986-2630
Website: http://www.mdbiosciences.com/
Email: info@mdbiosciences.com
24 articles about MD Biosciences
-
IncellDx and MD Biosciences Sign Definitive Agreement for Commercialization of COVID-19/Cytokine Storm Cytokine Panel and CCR5 Receptor Occupancy in US and EU
9/15/2020
IncellDx, Inc., a global leader in single-cell diagnostics, announces the signing of an agreement with MD Biosciences, Inc. for the commercialization of novel assays based on IncellDx's work on diagnostic, prognostic, and therapeutic biomarkers in COVID-19 and other cytokine storm conditions. Under the terms of the agreem
-
Prism Research and MD Biosciences Receive First Contract Award as Members of the Minnesota Clinical Research Hub (MCRH)
10/26/2017
MCRH today announced its first contract for a multi-site, Phase I clinical research study.
-
MD Biosciences Announces The Release Of A Diagnostic Test For Zika Virus
3/1/2016
-
MD Biosciences Announces Launch Of Its Onco-Immunology Suite Of Preclinical Services
1/27/2016
-
MD Biosciences Release: Imiquimod-Induced Psoriasis-Like Preclinical Model for Skin Inflammation
5/3/2012
-
MD Biosciences Launches a New Products Division, MD Bioproducts
10/6/2009
-
MD Biosciences Expansion to Increase Capacity in Pre-Clinical Drug Discovery Services and Products for Inflammatory and Neurological Diseases
10/6/2009
-
MD Biosciences Releases Tamm-Horsfall (Uromodulin) ELISA
7/6/2009
-
PharmaGap Inc. And MD Biosciences Announce a Collaboration to Pursue Development of a Novel PKC Theta Inhibitor for Inflammatory and Neurological Diseases
4/3/2009
-
PharmaGap Inc. And MD Biosciences Announce a Collaboration to Pursue Development of a Novel PKC Theta Inhibitor for Inflammatory and Neurological Diseases
3/16/2009
-
MD Biosciences CRO Division Expands Its Preclinical Contract Research Services by Offering Myocardial Infarct Models
3/4/2009
-
MD Biosciences Releases Human Collagen Type I (CI) ELISA
2/9/2009
-
MD Biosciences Releases Lumican and Keratocan Monoclonal Antibodies for Eye/Cornea Research
12/9/2008
-
MD Biosciences to Showcase Pre-Clinical Capabilities at the Neuroscience 2008 Conference
11/11/2008
-
MD Biosciences Showcases Its Products And Services At The 2008 APLAR Conference
9/23/2008
-
MD Biosciences to Present Preclinical Disease Models at the 15th International Inflammation Research Association Conference
9/16/2008
-
MD Biosciences Offers Monoarthritic Pain Model as a Preclinical Service
9/10/2008
-
MD Biosciences to Showcase Pre-Clinical Capabilities at the 12th World Congress on Pain
8/13/2008
-
MD Biosciences Releases Mouse OVA-IgE ELISA
8/3/2007
-
MD Biosciences Releases: Histology Results Show Significant Arthritogenic Activity of ArthritoMab(TM) Antibody Cocktail in an 18-Day Model of Rheumatoid Arthritis
7/18/2007